Am. J. Respir. Crit. Care Med., Vol 149, No. 6, 06 1994, 1583-1590.
Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis
AU Wells, P Cullinan, DM Hansell, MB Rubens, CM Black, AJ Newman-Taylor and RM Du Bois
Interstitial Lung Disease Unit, Royal Brompton National Heart and Lung Hospital, London, United Kingdom.
Fibrosing alveolitis associated with systemic sclerosis (FASSc) is
considered to be histologically and radiologically indistinguishable from
lone cryptogenic fibrosing alveolitis (CFA). To date, the natural history
of the two diseases has not been compared directly in large groups of
patients followed at a single institution. We evaluated the survival of 205
patients with CFA and 68 patients with FASSc. Deaths during the follow-up
period were reported in 142 patients with CFA (70%) and in 11 patients with
FASSc (16%). Unadjusted survival from the onset of dyspnea was less in CFA
than in FASSc (odds ratio, 3.3; p < 0.001); this difference persisted
after adjustment for age of onset of dyspnea and smoking history. Survival
from presentation was less in CFA (odds ratio approximately 3.3) after
adjustment for age of presentation, smoking history, and initial pulmonary
function indices. These differences persisted when analysis was confined to
patients with histologic confirmation of fibrosing alveolitis and after
adjustment for treatment. In patients undergoing computed tomography (CT)
of the lungs, survival was less in CFA after adjustment for extent of
abnormal lung on CT and CT pattern of disease (odds ratio, 3.9; p <
0.001). These findings indicate that despite their histologic and
radiologic similarities, lone CFA and FASSc have different courses.
This article has been cited by other articles:

|
 |

|
 |
 
D. Shitrit, Y. Gershman, N. Peled, B. Medalion, M. Saute, A. Amital, and M. R. Kramer
Risk factors for death while awaiting lung transplantation in Israeli patients: 1997-2006.
Eur. J. Cardiothorac. Surg.,
August 1, 2008;
34(2):
444 - 448.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Tzelepis, S. P. Toya, and H. M. Moutsopoulos
Occult connective tissue diseases mimicking idiopathic interstitial pneumonias
Eur. Respir. J.,
January 1, 2008;
31(1):
11 - 20.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. du Bois and T. E King Jr
Challenges in pulmonary fibrosis {middle dot} 5: The NSIP/UIP debate
Thorax,
November 1, 2007;
62(11):
1008 - 1012.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. BEREZNE, D. VALEYRE, B. RANQUE, L. GUILLEVIN, and L. MOUTHON
Interstitial Lung Disease Associated with Systemic Sclerosis: What Is the Evidence for Efficacy of Cyclophosphamide?
Ann. N.Y. Acad. Sci.,
September 1, 2007;
1110(1):
271 - 284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Park, D. S. Kim, I-N. Park, S. J. Jang, M. Kitaichi, A. G. Nicholson, and T. V. Colby
Prognosis of Fibrotic Interstitial Pneumonia: Idiopathic versus Collagen Vascular Disease-related Subtypes
Am. J. Respir. Crit. Care Med.,
April 1, 2007;
175(7):
705 - 711.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Gribbin, R B Hubbard, I Le Jeune, C J P Smith, J West, and L J Tata
Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK
Thorax,
November 1, 2006;
61(11):
980 - 985.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. P. Sylvester, S. R. Desai, A. U. Wells, D. M. Hansell, M. Awogbade, S. L. Thein, and A. Greenough
Computed tomography and pulmonary function abnormalities in sickle cell disease
Eur. Respir. J.,
October 1, 2006;
28(4):
832 - 838.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C Rigamonti, L M Shand, M Feudjo, C C Bunn, C M Black, C P Denton, and A K Burroughs
Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis
Gut,
March 1, 2006;
55(3):
388 - 394.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Desai, S. Veeraraghavan, D. M. Hansell, A. Nikolakopolou, N. S. L. Goh, A. G. Nicholson, T. V. Colby, C. P. Denton, C. M. Black, R. M. du Bois, et al.
CT Features of Lung Disease in Patients with Systemic Sclerosis: Comparison with Idiopathic Pulmonary Fibrosis and Nonspecific Interstitial Pneumonia
Radiology,
August 1, 2004;
232(2):
560 - 567.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. W. Hunninghake, D. A. Lynch, J. R. Galvin, B. H. Gross, N. Muller, D. A. Schwartz, T. E. King Jr, J. P. Lynch III, R. Hegele, J. Waldron, et al.
Radiologic Findings Are Strongly Associated With a Pathologic Diagnosis of Usual Interstitial Pneumonia
Chest,
October 1, 2003;
124(4):
1215 - 1223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Thabut, H. Mal, Y. Castier, O. Groussard, O. Brugiere, R. Marrash-Chahla, G. Leseche, and M. Fournier
Survival benefit of lung transplantation for patients with idiopathic pulmonary fibrosis
J. Thorac. Cardiovasc. Surg.,
August 1, 2003;
126(2):
469 - 475.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Renzoni, D. A. Walsh, M. Salmon, A. U. Wells, P. Sestini, A. G. Nicholson, S. Veeraraghavan, A. E. Bishop, H. M. Romanska, P. Pantelidis, et al.
Interstitial Vascularity in Fibrosing Alveolitis
Am. J. Respir. Crit. Care Med.,
February 1, 2003;
167(3):
438 - 443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. R. Collard and T. E. King Jr
Demystifying Idiopathic Interstitial Pneumonia
Arch Intern Med,
January 13, 2003;
163(1):
17 - 29.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Bouros, A. U. Wells, A. G. Nicholson, T. V. Colby, V. Polychronopoulos, P. Pantelidis, P. L. Haslam, D. A. Vassilakis, C. M. Black, and R. M. du Bois
Histopathologic Subsets of Fibrosing Alveolitis in Patients with Systemic Sclerosis and Their Relationship to Outcome
Am. J. Respir. Crit. Care Med.,
June 15, 2002;
165(12):
1581 - 1586.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Hubbard and A. Venn
The impact of coexisting connective tissue disease on survival in patients with fibrosing alveolitis
Rheumatology,
June 1, 2002;
41(6):
676 - 679.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Rajasekaran, D. Shovlin, P. Lord, and C. A. Kelly
Interstitial lung disease in patients with rheumatoid arthritis: a comparison with cryptogenic fibrosing alveolitis
Rheumatology,
September 1, 2001;
40(9):
1022 - 1025.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. W. HUNNINGHAKE, M. B. ZIMMERMAN, D. A. SCHWARTZ, T. E. KING JR., J. LYNCH, R. HEGELE, J. WALDRON, T. COLBY, N. MULLER, D. LYNCH, et al.
Utility of a Lung Biopsy for the Diagnosis of Idiopathic Pulmonary Fibrosis
Am. J. Respir. Crit. Care Med.,
July 15, 2001;
164(2):
193 - 196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R K Coker, G J Laurent, P K Jeffery, R M du Bois, C M Black, and R J McAnulty
Localisation of transforming growth factor {beta}1 and {beta}3 mRNA transcripts in normal and fibrotic human lung
Thorax,
July 1, 2001;
56(7):
549 - 556.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R.M. du Bois and A.U. Wells
Cryptogenic fibrosing alveolitis/idiopathic pulmonary fibrosis
Eur. Respir. J.,
July 1, 2001;
18(32_suppl):
43S - 55s.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lamblin, C. Bergoin, T. Saelens, and B. Wallaert
Interstitial lung diseases in collagen vascular diseases
Eur. Respir. J.,
July 1, 2001;
18(32_suppl):
69S - 80s.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.M. Anto and P. Cullinan
Clusters, classification and epidemiology of interstitial lung diseases: concepts, methods and critical reflections
Eur. Respir. J.,
July 1, 2001;
18(32_suppl):
101S - 106s.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J Fujita, T Yoshinouchi, Y Ohtsuki, M Tokuda, Y Yang, I Yamadori, S Bandoh, T Ishida, J Takahara, and R Ueda
Non-specific interstitial pneumonia as pulmonary involvement of systemic sclerosis
Ann Rheum Dis,
March 1, 2001;
60(3):
281 - 283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Harris, P. Cullinan, and J. C. McDonald
Occupational Distribution and Geographic Clustering of Deaths Certified To Be Cryptogenic Fibrosing Alveolitis in England and Wales
Chest,
February 1, 2001;
119(2):
428 - 433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. HUBBARD, A. VENN, S. LEWIS, and J. BRITTON
Lung Cancer and Cryptogenic Fibrosing Alveolitis . A Population-based Cohort Study
Am. J. Respir. Crit. Care Med.,
January 1, 2000;
161(1):
5 - 8.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. M Mitchell and A. Woodcock
Introduction
Thorax,
August 1, 1999;
54(90002):
S1 - 1.
[PDF]
|
 |
|

|
 |

|
 |
 
P. Paredi, S. A. Kharitonov, S. Loukides, P. Pantelidis, R. M. d. Bois, and P. J. Barnes
Exhaled Nitric Oxide Is Increased in Active Fibrosing Alveolitis
Chest,
May 1, 1999;
115(5):
1352 - 1356.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Akira, H. Hara, and M. Sakatani
Interstitial Lung Disease in Association with Polymyositis-Dermatomyositis: Long-term Follow-up CT Evaluation in Seven Patients
Radiology,
February 1, 1999;
210(2):
333 - 338.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. J. Avila, P. A. Lympany, P. Pantelidis, K. I. Welsh, C. M. Black, and R. M. du Bois
Fibronectin Gene Polymorphisms Associated with Fibrosing Alveolitis in Systemic Sclerosis
Am. J. Respir. Cell Mol. Biol.,
January 1, 1999;
20(1):
106 - 112.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
V. COTTIN, A.-V. DONSBECK, D. REVEL, R. LOIRE, and J.-F. CORDIER
Nonspecific Interstitial Pneumonia . Individualization of a Clinicopathologic Entity in a Series of 12 Patients
Am. J. Respir. Crit. Care Med.,
October 1, 1998;
158(4):
1286 - 1293.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. E. GAY, E. A. KAZEROONI, G. B. TOEWS, J. P. LYNCH III, B. H. GROSS, P. N. CASCADE, D. L. SPIZARNY, A. FLINT, M. ANTHONY SCHORK, R. I. WHYTE, et al.
Idiopathic Pulmonary Fibrosis . Predicting Response to Therapy and Survival
Am. J. Respir. Crit. Care Med.,
April 1, 1998;
157(4):
1063 - 1072.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.-L. A. KATZENSTEIN and J. L. MYERS
Idiopathic Pulmonary Fibrosis . Clinical Relevance of Pathologic Classification
Am. J. Respir. Crit. Care Med.,
April 1, 1998;
157(4):
1301 - 1315.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. IMOKAWA, A. SATO, H. HAYAKAWA, M. KOTANI, T. URANO, and A. TAKADA
Tissue Factor Expression and Fibrin Deposition in the Lungs of Patients with Idiopathic Pulmonary Fibrosis and Systemic Sclerosis
Am. J. Respir. Crit. Care Med.,
July 1, 1997;
156(2):
631 - 636.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
Corrigenda for vol. 155, p. 1367
Am. J. Respir. Crit. Care Med.,
July 1, 1997;
156(2):
676 - 677.
[Full Text]
|
 |
|

|
 |

|
 |
 
B. T. SOCIETY and S. O. C. COMMITTEE
The Diagnosis, Assessment and Treatment of Diffuse Parenchymal Lung Disease in Adults---British Thoracic Society recommendations
Thorax,
April 1, 1990;
54(90001):
1S - 28.
[Full Text]
|
 |
|

|
 |

|
 |
 
S. L. S. MacDonald, M. B. Rubens, D. M. Hansell, S. J. Copley, S. R. Desai, R. M. du Bois, A. G. Nicholson, T. V. Colby, and A. U. Wells
Nonspecific Interstitial Pneumonia and Usual Interstitial Pneumonia: Comparative Appearances at and Diagnostic Accuracy of Thin-Section CT
Radiology,
December 1, 2001;
221(3):
600 - 605.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1994 American Thoracic Society
|
|
|